The concepts of remission and recovery in schizophrenia.

作者: Robin Emsley , Bonginkosi Chiliza , Laila Asmal , Keneilwa Lehloenya

DOI: 10.1097/YCO.0B013E3283436EA3

关键词: Intensive care medicineSubjective well-beingPsychiatryQuality of lifeTreatment responseSchizophreniaOutcome (game theory)OperationalizationMedicineMEDLINEHealth care

摘要: Purpose of review Until recently outcome studies in schizophrenia lacked standardized measures, and expectations were generally pessimistic. The Remission Schizophrenia Working Group (RSWG) published operationalized criteria for symptomatic remission 2005. These have been extensively applied research settings stimulated into other components outcome, particularly functional quality life. Attention has also shifted beyond to the more difficult attain complex concept recovery. purpose this is examine recent on these topics assess whether progress made towards a broader definition Recent findings Reported rates vary widely across (17-88%). Patients do better than their nonremitted counterparts several domains. Predictors include early treatment response, baseline symptom severity subjective well being. move out over time. At present, there no consensus methods measuring domains, status Summary RSWG are easy apply define an achievable desirable goal. Measures social occupational life cognitive need be further developed before recovery can broadly defined.

参考文章(60)
N. M. Menezes, A. M. Malla, R. M. Norman, S. Archie, P. Roy, R. B. Zipursky, A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis. Acta Psychiatrica Scandinavica. ,vol. 120, pp. 138- 146 ,(2009) , 10.1111/J.1600-0447.2009.01346.X
Roger M.K. Ng, Veronica Pearson, May Lam, C.W. Law, Cindy P.Y. Chiu, Eric Y.H. Chen, What does recovery from schizophrenia mean? Perceptions of long-term patients. International Journal of Social Psychiatry. ,vol. 54, pp. 118- 130 ,(2008) , 10.1177/0020764007084600
Joseph Peuskens, Jitendra K. Trivedi, Martin Brecher, Frank Miller, Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study International Clinical Psychopharmacology. ,vol. 25, pp. 183- 187 ,(2010) , 10.1097/YIC.0B013E328337789B
Yoram Barak, Avi Bleich, Dov Aizenberg, Psychosocial remission in schizophrenia: developing a clinician-rated scale. Comprehensive Psychiatry. ,vol. 51, pp. 94- 98 ,(2010) , 10.1016/J.COMPPSYCH.2008.11.013
Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller, Michael Obermeier, Thomas Messer, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz G. Schmidt, Wolfgang Gaebel, Wolfgang Huff, Isabella Heuser, Wolfgang Maier, Matthias R. Lemke, Eckart Rüther, Gerd Buchkremer, Markus Gastpar, Hans-Jürgen Möller, Michael Riedel, Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophrenia Research. ,vol. 113, pp. 210- 217 ,(2009) , 10.1016/J.SCHRES.2009.05.032
Pierre-Michel Llorca, Christophe Lançon, Sylvie Lancrenon, Franck-Jean Bayle, Hervé Caci, Frédéric Rouillon, Philip Gorwood, The Functional Remission of General Schizophrenia (FROGS) scale: Development and validation of a new questionnaire Schizophrenia Research. ,vol. 113, pp. 218- 225 ,(2009) , 10.1016/J.SCHRES.2009.04.029
R. Schennach-Wolff, M. Jäger, F. Seemüller, M. Obermeier, M. Schmauss, G. Laux, H. Pfeiffer, D. Naber, L. G. Schmidt, W. Gaebel, J. Klosterkötter, I. Heuser, W. Maier, M. R. Lemke, E. Rüther, S. Klingberg, M. Gastpar, H.-J. Möller, M. Riedel, Outcome of suicidal patients with schizophrenia: results from a naturalistic study. Acta Psychiatrica Scandinavica. ,vol. 121, pp. 359- 370 ,(2010) , 10.1111/J.1600-0447.2009.01484.X
Lars Helldin, John M. Kane, Fredrik Hjärthag, Torsten Norlander, The importance of cross-sectional remission in schizophrenia for long-term outcome: A clinical prospective study Schizophrenia Research. ,vol. 115, pp. 67- 73 ,(2009) , 10.1016/J.SCHRES.2009.07.004
Alessandro Rossi, Anna Bagalà, Vincenzo Del Curatolo, Francesco Scapati, Micaela Maria Bernareggi, Maria Grazia Giustra, , Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder† Human Psychopharmacology-clinical and Experimental. ,vol. 24, pp. 574- 583 ,(2009) , 10.1002/HUP.1067
John M. Kane, David T. Crandall, Ronald N. Marcus, James Eudicone, Andrei Pikalov, William H. Carson, Wim Swyzen, Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks. Schizophrenia Research. ,vol. 95, pp. 143- 150 ,(2007) , 10.1016/J.SCHRES.2007.05.009